Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million Peoplenews2021-11-17T02:47:01+00:00November 17th, 2021|The New York Times|
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covidnews2021-11-05T19:13:46+00:00November 5th, 2021|The New York Times|
U.K. Authorizes Merck’s Antiviral Pill for Covid-19news2021-11-04T17:42:59+00:00November 4th, 2021|The New York Times|
Merck Will Share Formula for Its Covid Pill With Poor Countriesnews2021-10-27T21:07:22+00:00October 27th, 2021|The New York Times|
Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countriesnews2021-10-20T19:15:15+00:00October 20th, 2021|The New York Times|
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?news2021-10-17T21:15:06+00:00October 17th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
Asia-Pacific Countries Rush to Buy Merck Covid Pillnews2021-10-07T12:59:12+00:00October 7th, 2021|The New York Times|
La píldora contra la covid: así es como funcionanews2021-10-04T17:14:20+00:00October 4th, 2021|The New York Times|
